These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8867855)

  • 1. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione.
    Ouaissi A; Guevara-Espinoza A; Chabé F; Gomez-Corvera R; Taibi A
    Immunol Lett; 1995 Dec; 48(3):221-4. PubMed ID: 8867855
    [No Abstract]   [Full Text] [Related]  

  • 2. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages.
    Fernandez-Gomez R; Esteban S; Gomez-Corvera R; Zoulika K; Ouaissi A
    J Immunol; 1998 Apr; 160(7):3471-9. PubMed ID: 9531308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
    Millar AE; Kahn SJ
    Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of growth hormone and prolactin secretion in Trypanosoma cruzi-infected mammosomatotrophic cells.
    Corrêa-de-Santana E; Paez-Pereda M; Theodoropoulou M; Renner U; Stalla J; Stalla GK; Savino W
    Neuroimmunomodulation; 2009; 16(3):208-12. PubMed ID: 19246944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
    Miller MJ; Wrightsman RA; Manning JE
    Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells.
    Kierszenbaum F
    J Immunol; 1982 Nov; 129(5):2202-5. PubMed ID: 6811661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of Trypanosoma cruzi Tc52 released factor to a protein inducing apoptosis.
    Borges M; Cordeiro-da-Silva A; Vergnes B; Sereno D; Ouaissi A
    Tissue Cell; 2005 Dec; 37(6):469-78. PubMed ID: 16246387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection.
    Antúnez MI; Cardoni RL
    Exp Parasitol; 2004; 106(3-4):85-94. PubMed ID: 15172215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas' disease: TCRBV9 over-representation and sequence oligoclonality in the fine specificity of T lymphocytes in target tissues of damage.
    Tekiel V; Oliveira GC; Correa-Oliveira R; Sánchez D; González-Cappa SM
    Acta Trop; 2005 Apr; 94(1):15-24. PubMed ID: 15777704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages.
    Ramos-Ligonio A; López-Monteon A; Talamás-Rohana P; Rosales-Encina JL
    Parasite Immunol; 2004 Oct; 26(10):409-18. PubMed ID: 15752118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.